{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:31:08Z","timestamp":1782160268298,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","award":["18\/94"],"award-info":[{"award-number":["18\/94"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"International AIDS Vaccine Initiative","doi-asserted-by":"publisher","award":["UKZNRSA1001"],"award-info":[{"award-number":["UKZNRSA1001"]}],"id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DELTAS AFRICA INITIATIVE GRANT","award":["DEL-15-006"],"award-info":[{"award-number":["DEL-15-006"]}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107752\/Z\/15\/Z"],"award-info":[{"award-number":["107752\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The HIV-1 epidemic in sub-Saharan Africa is heterogeneous with diverse unevenly distributed subtypes and regional differences in prevalence. Subtype-specific differences in disease progression rate and transmission efficiency have been reported, but the underlying biological mechanisms have not been fully characterized. Here, we tested the hypothesis that the subtypes prevalent in the East Africa, where adult prevalence rate is higher, have lower viral replication capacity (VRC) than their West African counterparts where adult prevalence rates are lower.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>Gag-protease<\/jats:italic> sequencing was performed on 213 and 160 antiretroviral-na\u00efve chronically infected participants from West and East Africa respectively and bioinformatic tools were used to infer subtypes and recombination patterns. VRC of patient-derived <jats:italic>gag-protease<\/jats:italic> chimeric viruses from West (n\u2009=\u2009178) and East (n\u2009=\u2009114) Africa were determined using a green fluorescent protein reporter-based cell assay. Subtype and regional differences in VRC and amino acid variants impacting VRC were identified by statistical methods. CRF02_AG (65%, n\u2009=\u2009139), other recombinants (14%, n\u2009=\u200930) and pure subtypes (21%, n\u2009=\u200944) were identified in West Africa. Subtypes A1 (64%, n\u2009=\u2009103), D (22%, n\u2009=\u200935), or recombinants (14%, n\u2009=\u200922) were identified in East Africa. Viruses from West Africa had significantly higher VRC compared to those from East Africa (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), with subtype-specific differences found among strains within West and East Africa (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Recombination patterns showed a preference for subtypes D, G or J rather than subtype A in the p6 region of <jats:italic>gag<\/jats:italic>, with evidence that subtype-specific differences in this region impact VRC. Furthermore, the Gag A83V polymorphism was associated with reduced VRC in CRF02_AG. HLA-A*23:01 (<jats:italic>p<\/jats:italic>\u2009=\u20090.0014) and HLA-C*07:01 (<jats:italic>p<\/jats:italic>\u2009=\u20090.002) were associated with lower VRC in subtype A infected individuals from East Africa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although prevalent viruses from West Africa displayed higher VRC than those from East Africa consistent with the hypothesis that lower VRC is associated with higher population prevalence, the predominant CRF02_AG strain in West Africa displayed higher VRC than other prevalent strains suggesting that VRC alone does not explain population prevalence. The study identified viral and host genetic determinants of virus replication capacity for HIV-1 CRF02_AG and subtype A respectively, which may have relevance for vaccine strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12977-021-00554-4","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T11:04:02Z","timestamp":1620212642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa"],"prefix":"10.1186","volume":"18","author":[{"given":"Omotayo","family":"Farinre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Gounder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarylee","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Tongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis","family":"Kanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn K.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-3992","authenticated-orcid":false,"given":"Thumbi","family":"Ndung\u2019u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"554_CR1","unstructured":"UNAIDS. UNAIDS DATA 2019. 2019."},{"issue":"2","key":"554_CR2","first-page":"83","volume":"14","author":"RW Lihana","year":"2012","unstructured":"Lihana RW, Ssemwanga D, Abimiku A, Ndembi N. Update on HIV-1 diversity in Africa: a decade in review. AIDS Rev. 2012;14(2):83\u2013100.","journal-title":"AIDS Rev"},{"issue":"Suppl 4","key":"554_CR3","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1097\/00002030-200108004-00012","volume":"15","author":"L Morison","year":"2001","unstructured":"Morison L, Buve A, Zekeng L, Heyndrickx L, Anagonou S, Musonda R, et al. HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS. 2001;15(Suppl 4):S109\u201316.","journal-title":"AIDS"},{"issue":"2","key":"554_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/v2020503","volume":"2","author":"AF Santos","year":"2010","unstructured":"Santos AF, Soares MA. HIV Genetic Diversity and Drug Resistance. Viruses. 2010;2(2):503\u201331.","journal-title":"Viruses"},{"issue":"5","key":"554_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/COH.0000000000000090","volume":"9","author":"G Djomand","year":"2014","unstructured":"Djomand G, Quaye S, Sullivan PS. HIV epidemic among key populations in west Africa. Curr Opin HIV AIDS. 2014;9(5):506\u201313.","journal-title":"Curr Opin HIV AIDS"},{"key":"554_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1743-422X-10-29","volume":"10","author":"M Tongo","year":"2013","unstructured":"Tongo M, Martin DP, Zembe L, Mpoudi-Ngole E, Williamson C, Burgers WA. Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic. Virol J. 2013;10:29.","journal-title":"Virol J"},{"issue":"3","key":"554_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/COH.0000000000000534","volume":"14","author":"N Bbosa","year":"2019","unstructured":"Bbosa N, Kaleebu P, Ssemwanga D. HIV subtype diversity worldwide. Curr Opin HIV AIDS. 2019;14(3):153\u201360.","journal-title":"Curr Opin HIV AIDS"},{"key":"554_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","volume":"10","author":"AB Kharsany","year":"2016","unstructured":"Kharsany AB, Karim QA. HIV infection and AIDS in Sub-Saharan Africa: current status challenges and opportunities. Open AIDS J. 2016;10:34\u201348.","journal-title":"Open AIDS J"},{"issue":"3","key":"554_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.idc.2014.05.001","volume":"28","author":"J Fettig","year":"2014","unstructured":"Fettig J, Swaminathan M, Murrill CS, Kaplan JE. Global epidemiology of HIV. Infect Dis Clin North Am. 2014;28(3):323\u201337.","journal-title":"Infect Dis Clin North Am"},{"key":"554_CR10","first-page":"983","volume":"6","author":"D Serwadda","year":"1992","unstructured":"Serwadda D, Wawer MJ, Musgrave SD, Sewankambo NK, Kaplan JE, Gray RH. HIV risk factors in three geopgraphic strata of rural Rakai District. Uganda AIDS. 1992;6:983\u201390.","journal-title":"Uganda. AIDS."},{"issue":"1","key":"554_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1006\/cbmr.1999.1533","volume":"33","author":"B Auvert","year":"2000","unstructured":"Auvert B, Buonamico G, Lagarde E, Williams B. Sexual behavior, heterosexual transmission, and the spread of HIV in sub-Saharan Africa: a simulation study. Comput Biomed Res. 2000;33(1):84\u201396.","journal-title":"Comput Biomed Res"},{"key":"554_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200010200-00018","author":"HA Weiss","year":"2000","unstructured":"Weiss HA, Quigley MA. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000. https:\/\/doi.org\/10.1097\/00002030-200010200-00018.","journal-title":"AIDS"},{"issue":"7018","key":"554_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature03113","volume":"432","author":"P Kiepiela","year":"2004","unstructured":"Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature. 2004;432(7018):769\u201375.","journal-title":"Nature"},{"issue":"5840","key":"554_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.1143767","volume":"317","author":"J Fellay","year":"2007","unstructured":"Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317(5840):944\u20137.","journal-title":"Science"},{"issue":"1","key":"554_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2016.12.013","volume":"46","author":"C Gosmann","year":"2017","unstructured":"Gosmann C, Anahtar MN, Handley SA, Farcasanu M, Abu-Ali G, Bowman BA, et al. Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women. Immunity. 2017;46(1):29\u201337.","journal-title":"Immunity"},{"issue":"7213","key":"554_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nature07352","volume":"455","author":"DH Barouch","year":"2008","unstructured":"Barouch DH. Challenges in the development of an HIV-1 vaccine. Nature. 2008;455(7213):613\u20139.","journal-title":"Nature"},{"issue":"5","key":"554_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/infdis\/jit416","volume":"209","author":"AA Palm","year":"2014","unstructured":"Palm AA, Esbjornsson J, Mansson F, Kvist A, Isberg PE, Biague A, et al. Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3\/CRF02_AG compared with sub-subtype A3. J Infect Dis. 2014;209(5):721\u20138.","journal-title":"J Infect Dis"},{"issue":"1","key":"554_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1086\/314557","volume":"179","author":"PJ Kanki","year":"1999","unstructured":"Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis. 1999;179(1):68\u201373.","journal-title":"J Infect Dis"},{"issue":"3","key":"554_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00002030-200102160-00001","volume":"15","author":"P Kaleebu","year":"2001","unstructured":"Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, Rutebemberwa A, et al. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS. 2001;15(3):293\u20139.","journal-title":"AIDS"},{"issue":"5","key":"554_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1086\/527416","volume":"197","author":"N Kiwanuka","year":"2008","unstructured":"Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F, et al. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis. 2008;197(5):707\u201313.","journal-title":"J Infect Dis"},{"issue":"8","key":"554_CR21","doi-asserted-by":"publisher","first-page":"e71768","DOI":"10.1371\/journal.pone.0071768","volume":"8","author":"D Ssemwanga","year":"2013","unstructured":"Ssemwanga D, Nsubuga RN, Mayanja BN, Lyagoba F, Magambo B, Yirrell D, et al. Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study. PLoS ONE. 2013;8(8):e71768.","journal-title":"PLoS ONE"},{"key":"554_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ebiom.2016.10.014","volume":"13","author":"CM Venner","year":"2016","unstructured":"Venner CM, Nankya I, Kyeyune F, Demers K, Kwok C, Chen PL, et al. Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa. EBioMedicine. 2016;13:305\u201314.","journal-title":"EBioMedicine"},{"issue":"17","key":"554_CR23","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1097\/QAD.0000000000000012","volume":"27","author":"PN Amornkul","year":"2013","unstructured":"Amornkul PN, Karita E, Kamali A, Rida WN, Sanders EJ, Lakhi S, et al. Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. AIDS. 2013;27(17):2775\u201386.","journal-title":"AIDS"},{"issue":"10","key":"554_CR24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1089\/aid.2010.0054","volume":"26","author":"SA Conroy","year":"2010","unstructured":"Conroy SA, Laeyendecker O, Redd AD, Collinson-Streng A, Kong X, Makumbi F, et al. Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002. AIDS Res Hum Retroviruses. 2010;26(10):1087\u201391.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"e20492","DOI":"10.7554\/eLife.20492","volume":"5","author":"F Blanquart","year":"2016","unstructured":"Blanquart F, Grabowski MK, Herbeck J, Nalugoda F, Serwadda D, Eller MA, et al. A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda. Elife. 2016;5:e20492.","journal-title":"Elife"},{"issue":"12","key":"554_CR26","doi-asserted-by":"publisher","first-page":"e1007976","DOI":"10.1371\/journal.ppat.1007976","volume":"15","author":"NR Faria","year":"2019","unstructured":"Faria NR, Vidal N, Lourenco J, Raghwani J, Sigaloff KCE, Tatem AJ, et al. Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa. PLoS Pathog. 2019;15(12):e1007976.","journal-title":"PLoS Pathog"},{"issue":"11","key":"554_CR27","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1128\/JVI.02051-08","volume":"83","author":"A Abraha","year":"2009","unstructured":"Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, Johnston E, et al. CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. J Virol. 2009;83(11):5592\u2013605.","journal-title":"J Virol"},{"key":"554_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.111152698","author":"A Velazquez-Campoy","year":"2001","unstructured":"Velazquez-Campoy A, Todd MJ, Vega S, Freire E. Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes. PNAS. 2001. https:\/\/doi.org\/10.1073\/pnas.111152698.","journal-title":"PNAS"},{"issue":"53","key":"554_CR29","doi-asserted-by":"publisher","first-page":"44714","DOI":"10.1074\/jbc.M112.397158","volume":"287","author":"M Bachu","year":"2012","unstructured":"Bachu M, Yalla S, Asokan M, Verma A, Neogi U, Sharma S, et al. Multiple NF-kappaB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. J Biol Chem. 2012;287(53):44714\u201335.","journal-title":"J Biol Chem"},{"issue":"2","key":"554_CR30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1128\/JVI.77.2.1021-1038.2003","volume":"77","author":"SC Ball","year":"2003","unstructured":"Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, Quinones-Mateu ME, et al. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol. 2003;77(2):1021\u201338.","journal-title":"J Virol"},{"issue":"1","key":"554_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-10-100","volume":"10","author":"JK Mann","year":"2013","unstructured":"Mann JK, Byakwaga H, Kuang XT, Le AQ, Brumme CJ, Mwimanzi P, Omarjee S, Martin E, Lee GQ, Baraki B, Danroth R. Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes. Retrovirology. 2013;10(1):1\u20136.","journal-title":"Retrovirology"},{"issue":"10","key":"554_CR32","doi-asserted-by":"publisher","first-page":"8446","DOI":"10.1128\/JVI.72.10.8446-8452.1998","volume":"72","author":"MA Montano","year":"1998","unstructured":"Montano MA, Nixon CP, Essex M. Dysregulation through the NF-kB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter. J Virol. 1998;72(10):8446\u201352.","journal-title":"J Virol."},{"key":"554_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1742-4690-7-85","volume":"7","author":"S Iordanskiy","year":"2010","unstructured":"Iordanskiy S, Waltke M, Feng Y, Wood C. Subtype-associated differences in HIV-1 reverse transcription affect the viral replication. Retrovirology. 2010;7:85.","journal-title":"Retrovirology"},{"key":"554_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00293-20","author":"G Umviligihozo","year":"2020","unstructured":"Umviligihozo G, Cobarrubias KD, Chandrarathna S, Jin SW, Reddy N, Byakwaga H, et al. Differential Vpu-mediated CD4 and tetherin downregulation functions among major HIV-1 Group M subtypes. J Virol. 2020. https:\/\/doi.org\/10.1128\/JVI.00293-20.","journal-title":"J Virol."},{"issue":"20","key":"554_CR35","doi-asserted-by":"publisher","first-page":"10820","DOI":"10.1128\/JVI.01084-10","volume":"84","author":"JK Wright","year":"2010","unstructured":"Wright JK, Brumme ZL, Carlson JM, Heckerman D, Kadie CM, Brumme CJ, et al. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. J Virol. 2010;84(20):10820\u201331.","journal-title":"J Virol"},{"issue":"12","key":"554_CR36","doi-asserted-by":"publisher","first-page":"E1480","DOI":"10.1073\/pnas.1421607112","volume":"112","author":"DT Claiborne","year":"2015","unstructured":"Claiborne DT, Prince JL, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112(12):E1480\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"554_CR37","doi-asserted-by":"publisher","first-page":"e1003041","DOI":"10.1371\/journal.ppat.1003041","volume":"8","author":"JL Prince","year":"2012","unstructured":"Prince JL, Claiborne DT, Carlson JM, Schaefer M, Yu T, Lahki S, et al. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. PLoS Pathog. 2012;8(11):e1003041.","journal-title":"PLoS Pathog"},{"key":"554_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00253-17","author":"MW Kiguoya","year":"2017","unstructured":"Kiguoya MW, Mann JK, Chopera D, Gounder K, Lee GQ, Hunt PW, et al. Subtype-specific differences in Gag-protease-driven replication capacity are consistent with intersubtype differences in HIV-1 disease progression. J Virol. 2017. https:\/\/doi.org\/10.1128\/JVI.00253-17.","journal-title":"J Virol."},{"issue":"9","key":"554_CR39","doi-asserted-by":"publisher","first-page":"e1005154","DOI":"10.1371\/journal.ppat.1005154","volume":"11","author":"MJ Deymier","year":"2015","unstructured":"Deymier MJ, Ende Z, Fenton-May AE, Dilernia DA, Kilembe W, Allen SA, et al. Heterosexual transmission of subtype C HIV-1 selects consensus-like variants without increased replicative capacity or interferon-alpha resistance. PLoS Pathog. 2015;11(9):e1005154.","journal-title":"PLoS Pathog"},{"key":"554_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00518-17","author":"VL Naidoo","year":"2017","unstructured":"Naidoo VL, Mann JK, Noble C, Adland E, Carlson JM, Thomas J, et al. Mother-to-child HIV transmission bottleneck selects for consensus virus with lower gag-protease-driven replication capacity. J Virol. 2017. https:\/\/doi.org\/10.1128\/JVI.00518-17.","journal-title":"J Virol."},{"issue":"3","key":"554_CR41","doi-asserted-by":"publisher","first-page":"e17865","DOI":"10.1371\/journal.pone.0017865","volume":"6","author":"HO Ajoge","year":"2011","unstructured":"Ajoge HO, Gordon ML, de Oliveira T, Green TN, Ibrahim S, Shittu OS, et al. Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates. PLoS ONE. 2011;6(3):e17865.","journal-title":"PLoS ONE"},{"issue":"10","key":"554_CR42","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1089\/aid.2007.0037","volume":"23","author":"DJ Hamel","year":"2007","unstructured":"Hamel DJ, Sankale JL, Eisen G, Meloni ST, Mullins C, Gueye-Ndiaye A, et al. Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity. AIDS Res Hum Retroviruses. 2007;23(10):1189\u201396.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"554_CR43","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/infdis\/jiz127","volume":"220","author":"MA Price","year":"2019","unstructured":"Price MA, Rida W, Kilembe W, Karita E, Inambao M, Ruzagira E, et al. Control of the HIV-1 load varies by viral subtype in a large cohort of african adults with incident HIV-1 infection. J Infect Dis. 2019;220(3):432\u201341.","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"554_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0014-5793(91)80362-7","volume":"281","author":"J T\u00f6zs\u00e9r","year":"1991","unstructured":"T\u00f6zs\u00e9r J, Bl\u00e1ha I, Copeland TD, Wondrak EM, Oroszlan S. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins. FEBS Lett. 1991;281(1\u20132):77\u201380. https:\/\/doi.org\/10.1016\/0014-5793(91)80362-7.","journal-title":"FEBS Lett."},{"key":"554_CR45","doi-asserted-by":"publisher","first-page":"W647","DOI":"10.1093\/nar\/gkp371","volume":"37","author":"AK Schultz","year":"2009","unstructured":"Schultz AK, Zhang M, Bulla I, Leitner T, Korber B, Morgenstern B, et al. jpHMM: improving the reliability of recombination prediction in HIV-1. Nucleic Acids Res. 2009;37:W647\u201351.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"554_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/JVI.73.1.152-160.1999","volume":"73","author":"KS Lole","year":"1999","unstructured":"Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73(1):9.","journal-title":"J Virol"},{"issue":"1","key":"554_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/JVI.01471-08","volume":"83","author":"T Miura","year":"2009","unstructured":"Miura T, Brockman MA, Brumme ZL, Brumme CJ, Pereyra F, Trocha A, et al. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. J Virol. 2009;83(1):140\u20139.","journal-title":"J Virol"},{"issue":"2","key":"554_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jviromet.2005.08.003","volume":"131","author":"MA Brockman","year":"2006","unstructured":"Brockman MA, Tanzi GO, Walker BD, Allen TM. Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry. J Virol Methods. 2006;131(2):134\u201342.","journal-title":"J Virol Methods"},{"issue":"6","key":"554_CR49","doi-asserted-by":"publisher","first-page":"e98908","DOI":"10.1371\/journal.pone.0098908","volume":"9","author":"DM Edson Delatorre","year":"2014","unstructured":"Edson Delatorre DM, Bello G. Spatiotemporal dynamics of the HIV-1 subtype G epidemic in West and Central Africavv. PLoS ONE. 2014;9(6):e98908.","journal-title":"PLoS ONE"},{"key":"554_CR50","first-page":"313","volume":"35","author":"PB MonicaGandhi","year":"2001","unstructured":"MonicaGandhi PB, Miotti P, Quinn TC, Veronese F, Greenblatt RM. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis. 2001;35:313\u201322.","journal-title":"Clin Infect Dis."},{"issue":"6010","key":"554_CR51","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1195271","volume":"330","author":"F Pereyra","year":"2010","unstructured":"Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010;330(6010):1551\u20137.","journal-title":"Science"},{"issue":"3","key":"554_CR52","first-page":"10","volume":"76","author":"TP Barbara Muller","year":"2002","unstructured":"Barbara Muller TP, Hans-Georg K. The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles. J Virol. 2002;76(3):10.","journal-title":"J Virol."},{"issue":"19","key":"554_CR53","doi-asserted-by":"publisher","first-page":"eoo811","DOI":"10.1128\/JVI.00811-18","volume":"92","author":"DBA Ojwach","year":"2018","unstructured":"Ojwach DBA, Reddy T, Novitsky V, Brumme ZL, Brockman MA, Ndung\u2019u T, Mann JK. Pol-driven replicative capacity impacts disease progression in hiv-1 subtype C infection. J Virol. 2018;92(19):eoo811.","journal-title":"J Virol."},{"issue":"7","key":"554_CR54","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JVI.03233-12","volume":"87","author":"CL Boutwell","year":"2013","unstructured":"Boutwell CL, Carlson JM, Lin TH, Seese A, Power KA, Peng J, et al. Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins. J Virol. 2013;87(7):3952\u201365.","journal-title":"J Virol"},{"issue":"2","key":"554_CR55","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.micinf.2018.10.001","volume":"21","author":"N Takahashi","year":"2019","unstructured":"Takahashi N, Matsuoka S, Thi Minh TT, Ba HP, Naruse TK, Kimura A, et al. Human leukocyte antigen-associated gag and nef polymorphisms in HIV-1 subtype A\/E-infected individuals in Vietnam. Microbes Infect. 2019;21(2):113\u20138.","journal-title":"Microbes Infect"},{"issue":"22","key":"554_CR56","doi-asserted-by":"publisher","first-page":"11937","DOI":"10.1128\/JVI.01086-10","volume":"84","author":"MA Brockman","year":"2010","unstructured":"Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, et al. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol. 2010;84(22):11937\u201349.","journal-title":"J Virol"},{"issue":"3","key":"554_CR57","doi-asserted-by":"publisher","first-page":"a007187","DOI":"10.1101\/cshperspect.a007187","volume":"2","author":"Y Shao","year":"2012","unstructured":"Shao Y, Williamson C. The HIV-1 epidemic: low- to middle-income countries. Cold Spring Harb Perspect Med. 2012;2(3):a007187.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"554_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11904-013-0160-1","volume":"10","author":"KQ Abdool","year":"2013","unstructured":"Abdool KQ. The global HIV epidemic: current status and challenges. Curr HIV\/AIDS Rep. 2013;10(2):111\u20132.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"554_CR59","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1473-3099(18)30647-9","volume":"19","author":"J Hemelaar","year":"2019","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, et al. Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019;19(2):143\u201355.","journal-title":"Lancet Infect Dis"},{"key":"554_CR60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.aids.0000198082.16960.94","volume":"20","author":"EG JoriHemelaar","year":"2006","unstructured":"JoriHemelaar EG, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006;20:11.","journal-title":"AIDS"},{"issue":"2","key":"554_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/viro.2001.1059","volume":"287","author":"JT Blackard","year":"2001","unstructured":"Blackard JT, Renjifo B, Fawzi W, Hertzmark E, Msamanga G, Mwakagile D, et al. HIV-1 LTR subtype and perinatal transmission. Virology. 2001;287(2):261\u20135.","journal-title":"Virology"},{"issue":"2","key":"554_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1590\/S0036-46652006000200004","volume":"48","author":"GN Odaibo","year":"2006","unstructured":"Odaibo GN, Heyndrickx L, Vereecken K, Houwer K, Jassens W. Mother-to-child transmission of different hiv-1 subtypes among arv naive iinfected pregnant woment in Nigeria. Rev Inst Med Trop S Paulo. 2006;48(2):77\u201380.","journal-title":"Rev Inst Med Trop S Paulo."},{"issue":"18","key":"554_CR63","first-page":"2479","volume":"23","author":"N Kiwanuka","year":"2009","unstructured":"Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, et al. HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai. Uganda AIDS. 2009;23(18):2479\u201384.","journal-title":"Uganda AIDS"},{"issue":"6","key":"554_CR64","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1086\/499952","volume":"42","author":"A Vasan","year":"2006","unstructured":"Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis . 2006;42(6):843\u201352.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"554_CR65","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/512682","volume":"195","author":"JM Baeten","year":"2007","unstructured":"Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis. 2007;195(8):1177\u201380.","journal-title":"J Infect Dis"},{"issue":"1","key":"554_CR66","doi-asserted-by":"publisher","first-page":"a006841","DOI":"10.1101\/cshperspect.a006841","volume":"1","author":"PM Sharp","year":"2011","unstructured":"Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1(1):a006841.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"100","key":"554_CR67","first-page":"1","volume":"10","author":"K Jaclyn","year":"2013","unstructured":"Jaclyn K, et al. Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes. Retrovirology. 2013;10(100):1\u201316.","journal-title":"Retrovirology"},{"issue":"9","key":"554_CR68","doi-asserted-by":"publisher","first-page":"e1008813","DOI":"10.1371\/journal.ppat.1008813","volume":"16","author":"SW Jin","year":"2020","unstructured":"Jin SW, Mwimanzi FM, Mann JK, Bwana MB, Lee GQ, Brumme CJ, et al. Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5. PLoS Pathog. 2020;16(9):e1008813.","journal-title":"PLoS Pathog"},{"issue":"8","key":"554_CR69","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1128\/JVI.02520-10","volume":"85","author":"JK Wright","year":"2011","unstructured":"Wright JK, Novitsky V, Brockman MA, Brumme ZL, Brumme CJ, Carlson JM, et al. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. J Virol. 2011;85(8):3996\u20134006.","journal-title":"J Virol"},{"issue":"2","key":"554_CR70","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.bbamem.2012.11.010","volume":"1828","author":"SM Solbak","year":"2013","unstructured":"Solbak SM, Reksten TR, Hahn F, Wray V, Henklein P, Henklein P, et al. HIV-1 p6 - a structured to flexible multifunctional membrane-interacting protein. Biochim Biophys Acta. 2013;1828(2):816\u201323.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"554_CR71","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jmv.24610","volume":"89","author":"SG Aralaguppe","year":"2017","unstructured":"Aralaguppe SG, Winner D, Singh K, Sarafianos SG, Quinones-Mateu ME, Sonnerborg A, et al. Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa. J Med Virol. 2017;89(1):106\u201311.","journal-title":"J Med Virol"},{"issue":"7238","key":"554_CR72","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nature07746","volume":"458","author":"Y Kawashima","year":"2009","unstructured":"Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature. 2009;458(7238):641\u20135.","journal-title":"Nature"},{"issue":"23","key":"554_CR73","doi-asserted-by":"publisher","first-page":"12636","DOI":"10.1128\/JVI.01236-09","volume":"83","author":"LR McKinnon","year":"2009","unstructured":"McKinnon LR, Capina R, Peters H, Mendoza M, Kimani J, Wachihi C, et al. Clade-specific evolution mediated by HLA-B*57\/5801 in human immunodeficiency virus type 1 clade A1 p24. J Virol. 2009;83(23):12636\u201342.","journal-title":"J Virol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-021-00554-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12977-021-00554-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-021-00554-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T11:14:06Z","timestamp":1675250046000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-021-00554-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1186\/s12977-021-00554-4","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"assertion":[{"value":"24 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (BE 313\/16). Written informed consent was obtained from all study participants at the time of recruitment and patient identity remained confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}